These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 7525853

  • 1. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.
    Strassmann G, Patil-Koota V, Finkelman F, Fong M, Kambayashi T.
    J Exp Med; 1994 Dec 01; 180(6):2365-70. PubMed ID: 7525853
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM, Barnes PJ, Giembycz MA.
    Cell Biochem Biophys; 1998 Dec 01; 29(1-2):179-201. PubMed ID: 9631245
    [Abstract] [Full Text] [Related]

  • 3. Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages.
    Chen BC, Hsieh SL, Lin WW.
    J Leukoc Biol; 2001 Feb 01; 69(2):280-8. PubMed ID: 11272279
    [Abstract] [Full Text] [Related]

  • 4. Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10.
    Zinyama RB, Bancroft GJ, Sigola LB.
    Immunology; 2001 Dec 01; 104(4):439-46. PubMed ID: 11899430
    [Abstract] [Full Text] [Related]

  • 5. IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes.
    Kambayashi T, Jacob CO, Strassmann G.
    Cell Immunol; 1996 Jul 10; 171(1):153-8. PubMed ID: 8660851
    [Abstract] [Full Text] [Related]

  • 6. Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10.
    Kambayashi T, Alexander HR, Fong M, Strassmann G.
    J Immunol; 1995 Apr 01; 154(7):3383-90. PubMed ID: 7897221
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y, Liu J, Wang LZ, Zhang WY, Zhu XZ.
    Acta Pharmacol Sin; 2005 Aug 01; 26(8):952-8. PubMed ID: 16038627
    [Abstract] [Full Text] [Related]

  • 8. In vitro effects of cAMP-elevating agents and glucocorticoid either alone or in combination on the production of nitric oxide, interleukin-12 and interleukin-10 in IFN-gamma- and LPS-activated mouse peritoneal macrophages.
    Mittal J, Dogra N, Dass R, Majumdar S.
    Folia Microbiol (Praha); 2002 Aug 01; 47(6):709-16. PubMed ID: 12630324
    [Abstract] [Full Text] [Related]

  • 9. Human interleukin 10 suppresses production of inflammatory mediators by LPS-stimulated equine peritoneal macrophages.
    Hawkins DL, MacKay RJ, MacKay SL, Moldawer LL.
    Vet Immunol Immunopathol; 1998 Nov 06; 66(1):1-10. PubMed ID: 9847016
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic induction of IL-10 by hypertonic saline solution and lipopolysaccharides in murine peritoneal macrophages.
    Oreopoulos GD, Bradwell S, Lu Z, Fan J, Khadaroo R, Marshall JC, Li YH, Rotstein OD.
    Surgery; 2001 Aug 06; 130(2):157-65. PubMed ID: 11490344
    [Abstract] [Full Text] [Related]

  • 12. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
    Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, Bazzoni F.
    J Immunol; 2002 Jun 15; 168(12):6404-11. PubMed ID: 12055259
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Staphylococcal glycocalyx activates macrophage prostaglandin E2 and interleukin 1 production and modulates tumor necrosis factor alpha and nitric oxide production.
    Stout RD, Li Y, Miller AR, Lambe DW.
    Infect Immun; 1994 Oct 15; 62(10):4160-6. PubMed ID: 7927671
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation of IL 6, IL 1 A, IL 1 beta and TNF alpha production in LPS-stimulated human monocytes: role of cyclic AMP.
    Bailly S, Ferrua B, Fay M, Gougerot-Pocidalo MA.
    Cytokine; 1990 May 15; 2(3):205-10. PubMed ID: 1716487
    [Abstract] [Full Text] [Related]

  • 17. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK, Cho W, Sung SH, Lee KT.
    J Pharmacol Exp Ther; 2012 Sep 15; 342(3):654-64. PubMed ID: 22637723
    [Abstract] [Full Text] [Related]

  • 18. Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity.
    Ding AH, Nathan CF.
    J Immunol; 1987 Sep 15; 139(6):1971-7. PubMed ID: 3040860
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate inhibits LPS-induced tumor necrosis factor production in vivo.
    Durez P, Appelboom T, Vray B, Pira C, Goldman M.
    Eur Cytokine Netw; 1998 Dec 15; 9(4):669-72. PubMed ID: 9889412
    [Abstract] [Full Text] [Related]

  • 20. Geniposide suppresses LPS-induced nitric oxide, PGE2 and inflammatory cytokine by downregulating NF-κB, MAPK and AP-1 signaling pathways in macrophages.
    Shi Q, Cao J, Fang L, Zhao H, Liu Z, Ran J, Zheng X, Li X, Zhou Y, Ge D, Zhang H, Wang L, Ran Y, Fu J.
    Int Immunopharmacol; 2014 Jun 15; 20(2):298-306. PubMed ID: 24735815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.